Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag in TPO-RA Refractory Aplastic Anemia
NCT05518331Phase 2Recruiting
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Jun 2022
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of avatrombopag in aplastic anemia, sponsored by Institute of Hematology and Blood Diseases Hospital. Started Jun 2022; status: recruiting.
02
Drugs
avatrombopag
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT05518331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05518331.